The Influence of Appetite-Related Central and Gut Hormones in Modulating Binge Eating Behaviour in Obese and Overweight Healthy Subjects

Trial Profile

The Influence of Appetite-Related Central and Gut Hormones in Modulating Binge Eating Behaviour in Obese and Overweight Healthy Subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 May 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Binge-Eating Disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2015 Results (obese patients n=42) presented at The 97th Annual Meeting of the Endocrine Society.
    • 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.
    • 08 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top